Cargando…
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
Annexin A1, a well-known endogenous anti-inflammatory mediator, plays a critical role in a variety of pathological processes. Fibrosis is described by a failure of tissue regeneration and contributes to the development of many diseases. Accumulating evidence supports that Annexin A1 participates in...
Autores principales: | Yan, Zhibin, Cheng, Xurui, Wang, Tao, Hong, Xiangyu, Shao, Gang, Fu, Caiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485289/ https://www.ncbi.nlm.nih.gov/pubmed/36157506 http://dx.doi.org/10.1016/j.gendis.2022.05.038 |
Ejemplares similares
-
Targeting Annexin A1 as a Druggable Player to Enhance the Anti-Tumor Role of Honokiol in Colon Cancer through Autophagic Pathway
por: Wang, Xi, et al.
Publicado: (2023) -
Therapeutic peptides: current applications and future directions
por: Wang, Lei, et al.
Publicado: (2022) -
Advancements of Annexin A1 in inflammation and tumorigenesis
por: Shao, Gang, et al.
Publicado: (2019) -
A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer
por: Shi, Yue, et al.
Publicado: (2021) -
Annexin-A1: Therapeutic Potential in Microvascular Disease
por: Purvis, Gareth S. D., et al.
Publicado: (2019)